Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods
- 21 November 2006
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 81A (1), 161-170
- https://doi.org/10.1002/jbm.a.30914
Abstract
The purpose of this study was to evaluate the antitumor efficacy and local drug distribution from doxorubicin-containing poly(D,L-lactide-co-glycolide) (PLGA) implants for intratumoral treatment of liver cancer in a rabbit model. Cylindrical polymer millirods (length 8 mm, diameter 1.5 mm) were produced using 65% PLGA, 21.5% NaCl, and 13.5% doxorubicin. These implants were placed in the center of VX2 liver tumors (n = 16, ˜8 mm in diameter) in rabbits. Tumors were removed 4 and 8 days after millirod implantation, and antitumor efficacy was assessed using tumor size measurements, tumor histology, and fluorescent measurement of drug distribution. The treated tumors were smaller than the untreated controls on both day 4 (0.17 ± 0.06 vs. 0.31 ± 0.08 cm2, p = 0.048) and day 8 (0.14 ± 0.04 vs. 1.8 ± 0.8 cm2, p = 0.025). Drug distribution profiles demonstrated high doxorubicin concentrations (>1000 μg/g) at the tumor core at both time points and drug penetration distances of 2.8 and 1.3 mm on day 4 and 8, respectively. Histological examination confirmed necrosis throughout the tumor tissue. Biodegradable polymer millirods successfully treated the primary tumor mass by providing high doxorubicin concentrations to the tumor tissue over an eight day period. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res 2007Keywords
This publication has 45 references indexed in Scilit:
- Current Imaging Paradigms in Radiation OncologyRadiation Research, 2005
- Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by PolymersInvestigational New Drugs, 2004
- Combined Intrapleural and Intravenous Chemotherapy, and Pulmonary Irradiation, for Treatment of Patients with Lung Cancer Presenting with Malignant Pleural EffusionOncology, 2002
- Evidence for the use of chemotherapy in breast cancerInternational Journal of Clinical Oncology, 2002
- Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug deliveryJournal of Pharmacy and Pharmacology, 2002
- Systemic therapy for hepatocellular carcinomaSeminars in Oncology, 2001
- Nonsurgical treatment of hepatocellular carcinomaSeminars in Oncology, 2001
- Radiofrequency tumor ablation: principles and techniquesEuropean Journal of Ultrasound, 2001
- Interventional MR: interstitial therapyEuropean Radiology, 1999
- Cryosurgical ablation of unresectable hepatic metastasesJournal of Surgical Oncology, 1998